MM
PRME icon

MWG Management’s Prime Medicine PRME Stock Holding History

MWG Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.93M Hold
1,792,210
– – 12.21% 3
2025
Q2 		$4.43M Hold
1,792,210
– – 8.53% 3
2025
Q1 		$3.57M Hold
1,792,210
– – 6.08% 3
2024
Q4 		$5.23M Hold
1,792,210
– – 7.04% 3
2024
Q3 		$6.94M Hold
1,792,210
– – 7.68% 3
2024
Q2 		$9.21M Hold
1,792,210
– – 10.06% 3
2024
Q1 		$12.5M Hold
1,792,210
– – 9.29% 3
2023
Q4 		$15.9M Hold
1,792,210
– – 13.36% 3
2023
Q3 		$17.1M Hold
1,792,210
– – 16.57% 3
2023
Q2 		$26.3M Sell
1,792,210
-43,666
-2% -$610K 15.88% 3
2023
Q1 		$22.6M Hold
1,835,876
– – 15.9% 3
2022
Q4 		$34.1M Buy
+1,835,876
New +$33.2M 17.42% 3

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

MWG Management's PRME Position: Q3 2025 in Review

MWG Management held its Prime Medicine (PRME) position steady in Q3 2025 at 1,792,210 shares worth $9.93M. The position accounts for 12.21% of the portfolio, ranked #3.

MWG Management first reported a position in PRME in Q4 2022 and has held it in 12 quarters since. The position peaked at $34.1M in Q4 2022. 167 funds tracked by Wall St. Rank hold PRME as of Q3 2025.

  • MWG Management held 1,792,210 shares of Prime Medicine worth $9.93M as of Q3 2025.
  • MWG Management left its Prime Medicine share count unchanged in Q3 2025.
  • Prime Medicine made up 12.21% of MWG Management's portfolio in Q3 2025, its #3 holding.
  • MWG Management first reported a position in Prime Medicine in Q4 2022 and has held it in 12 quarters since.
  • MWG Management's Prime Medicine position peaked at $34.1M in Q4 2022.
  • 167 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2025.

Based on MWG Management's 13F filing for Q3 2025, filed 12 Nov 2025.